Metabolic Syndrome (MS) is a complex disorder, characterized by interrelated metabolic abnormalities. Abdominal obesity is considered a trigger for MS, which represents a risk factor for diseases interconnected by the genesis of insulin resistance.
The most recent definition for MS was described by the International Diabetes Federation (IDF) in 2009], featuring MS as an association of factors like: hypertriglyceridemia (plasma triglyceride levels greater than or equal to 150 mg/dL), low plasma levels of HDL cholesterol (less than 40 mg/dL for men and 50 mg/dL for women), increased plasma glucose levels (greater than or equal to 100 mg/dL), type 2 diabetes mellitus diagnosis, and/or elevated systemic arterial blood pressure (greater than or equal to 130/85 mmHg). Such concept can be easily employed as a diagnostic tool in clinical practice to ascertain the patientâs metabolic and cardiovascular risk, which serves as a guide for their treatment.
Effect of Dietetic Intervention in Brazilian Postmenopausal Women with
Metabolic Syndrome: Viviane do Valle Couto Reis, Gabriela Morgado de Oliveira Coelho, Eliane de Abreu Soares and Avany Fernandes Pereira
Last date updated on April, 2024
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi